Table 2.
Clinical and laboratory findings in studied cases according to presence of HF and modified Ross score
| Clinical data | Total cases (n = 164) | HF group (n = 60) | No HF group (n = 104) | p value | Degree of HF | p value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mild cases (n = 37) | Moderate/severe (n = 23) | |||||||||||
| No. | % | No. | % | No. | % | No. | % | No. | % | |||
| RD grade | < 0.001* | |||||||||||
| Grade I | 74 | 45.1% | 25 | 41.7 | 49 | 47.1 | 22 | 59.5 | 3 | 13.0 | ||
| Grade II | 67 | 40.9% | 18 | 30.0 | 49 | 47.1 | 12 | 32.4 | 6 | 26.1 | < 0.001* | |
| Grade III | 18 | 10.9% | 12 | 20.0 | 6 | 5.8 | 3 | 8.1 | 9 | 39.1 | ||
| Grade IV | 5 | 3.0% | 5 | 8.3 | 0 | 0.0 | 0 | 0.0 | 5 | 21.7 | ||
| Cyanosis | 5 | 3.0% | 5 | 8.3 | 0 | 0 | 0.006* | 0 | 0.0 | 5 | 21.7 | 0.006* |
| Edema | 6 | 3.7% | 6 | 10 | 0 | 0 | 0.002* | 1 | 2.7 | 5 | 21.7 | 0.027* |
| Hepatomegaly | 24 | 14.6% | 24 | 40 | 0 | 0 | < 0.001* | 9 | 24.3 | 15 | 65.2 | 0.002* |
| Tachycardia for age | 51 | 31.1% | 51 | 85.0 | 0 | 0.0 | < 0.001* | 29 | 78.4 | 22 | 95.7 | 0.134 |
| Diminished perfusion | 7 | 4.3% | 7 | 11.7 | 0 | 0.0 | 0.001* | 0 | 0.0 | 7 | 30.4 | 0.001* |
| Diaphoresis | 30 | 18.3% | 30 | 50.0 | 0 | 0.0 | < 0.001* | 11 | 29.7 | 19 | 82.6 | < 0.001* |
| Prognosis | ||||||||||||
| Good (discharge) | 154 | 93.9% | 50 | 83.3 | 104 | 100.0 | < 0.001* | 37 | 100.0 | 13 | 56.5 | < 0.001* |
| Poor (death) | 10 | 6.1% | 10 | 16.7 | 0 | 0.0 | 0 | 0.0 | 10 | 43.5 | ||
| Laboratory findings | ||||||||||||
| NLR | 23 | 14.0% | 23 | 38.3 | 0 | 0.0 | < 0.001* | 1 | 2.7 | 22 | 95.7 | < 0.001* |
| Leukocytosis | 148 | 90.2% | 60 | 100.0 | 88 | 84.6 | 0.001* | 37 | 100.0 | 23 | 100.0 | – |
| CRP | 123 | 75.0% | 49 | 81.7 | 74 | 71.2 | 0.134 | 30 | 81.1 | 19 | 82.6 | 1.000 |
Qualitative data are presented as n (%). Significance defined by p < 0.05
HF heart failure, RD respiratory distress, CRP C-reactive protein